Finally, in Reverse Phase Protein Array (RPPA) of SKCM cohorts, the protein levels of LCK and CD20 were higher in low-risk group, suggesting a boost of the anti-tumor immune response (Fig. 5H, I). This evidence concerns the gene LCK and neoplasm.